Individuals with adult‐onset T1D typically exhibit a lower genetically determined risk and show a progressive loss of multiple diabetes‐associated autoantibodies over time, with glutamic acid decarboxylase (GAD) antibodies being the most persistent. The gene discussed is GAD1; the disease is type 1 diabetes mellitus.